Found: 9
Select item for more details and to access through your institution.
Deep Learning--based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 2, p. 218, doi. 10.1513/AnnalsATS.202301-084OC
- By:
- Publication type:
- Article
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1121, doi. 10.1164/rccm.202307-1191OC
- By:
- Publication type:
- Article
Deep Learning Assessment of Progression of Emphysema and Fibrotic Interstitial Lung Abnormality.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 6, p. 666, doi. 10.1164/rccm.202211-2098OC
- By:
- Publication type:
- Article
Deep Learning Assessment of Progression of Emphysema and Fibrotic Interstitial Lung Abnormality.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 6, p. E1, doi. 10.1164/rccm.202211-2098oc
- By:
- Publication type:
- Article
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 5, p. 587, doi. 10.1164/rccm.202206-1075OC
- By:
- Publication type:
- Article
The Use of the Net Promoter Score (NPS) in an Outpatient Allergy and Pulmonary Clinic: An Innovative Look into Using Tablet-Based Tool vs Traditional Survey Method.
- Published in:
- Patient Related Outcome Measures, 2020, v. 11, p. 137, doi. 10.2147/PROM.S248431
- By:
- Publication type:
- Article
Quantitative imaging analysis detects subtle airway abnormalities in symptomatic military deployers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2021, p. 1, doi. 10.1177/17534666211004238
- By:
- Publication type:
- Article
The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2021, p. 1, doi. 10.1177/17534666211004238
- By:
- Publication type:
- Article